NHS England has publicly listed 29 hospital trusts on its website as those "realising benefits" from the Federated Data Platform (FDP), yet these 29 trusts have responded that the system is not operational or that they do not use any of its applications. One senior health official described the discrepancy between the NHS’s claim and the trusts’ own understanding as "very misleading".
The Federated Data Platform is described as controversial and worth £330 million. NHS England states on its website that 137 trusts are "active" with the FDP, and of those described as "realising benefits", 29 have responded that they do not use the system or its applications. Epsom and St Helier stated that it "currently does not use the FDP". Kent and Medway noted that the trust has "focused on other priorities … the FDP is not currently operational". Mersey Care said it has "not yet put the FDP into operation", Nottingham University Hospitals said "no implementation plan has been agreed", and University Hospitals of North Midlands said the "FDP is not operational" and that it "does not intend to introduce it in the future".
NHS England maintains that nearly 140 trusts have "now reported benefits from the wide range of tools available on the platform, helping staff to connect and improve patient care and work more efficiently". NHS England previously stated that its list of hospital trusts reporting benefits includes those using the tools for data analysis in back-office administrative tasks and their delivery, rather than for supporting patient care. It is understood that trusts claiming not to use the FDP may be using a small part of its functionality for calculating treatment costs. Torbay and South Devon NHS Foundation Trust stated that it "currently does not operationally use the FDP", and NHS England records this trust as "active" because the infrastructure has been established "to support data delivery, not for active operational use of FDP applications".
NHS England claims that 117,539 additional operations were performed in trusts using the FDP over one year. This summer, NHS England admitted that it could not prove a causal link. The Office for Statistics Regulation (OSR) conducted an investigation and announced that it would now "continue to lead this within its case resolution function". The contrast emerged from more than 100 freedom of information requests, obtained by the medical charity Medact, which campaigns to remove Palantir from the NHS, and shared with the Guardian.
Health Secretary Yvette Cooper faces calls from MPs and activists to cancel the contract with the American technology firm for the delivery of the leading government AI system. The system is intended to connect scattered medical records, speed up hospital discharges and improve operation scheduling, among other potentially life-saving improvements. Chi Onwurah, chair of the House of Commons Science and Technology Committee, stated: "If many NHS trusts do not see the value of the FDP, serious questions must be asked as to whether the hype around Palantir’s products matches reality." She called on the government to trigger the 2027 termination clause in Palantir’s contract and launch an open tender for a UK-based data processing supplier. The House of Commons Health Committee is also calling on ministers to withdraw Palantir’s contract.
Medact spokesperson Dr Rhiannon Mihranian Osborne said: "Our NHS institutions should work in the interest of public trust and evidence-based healthcare, not use creative accounting to justify a deeply controversial contract. There is no good reason for the government to continue this failed project. We must now ask, if ministers are using these flawed claims for their decisions, are they being misled?"
Louis Mosley, Palantir’s chief executive for the UK and Europe, said that terminating the contract would be "putting politics above patients" and accused critics of "Palantir paranoia syndrome". The firm has contracts to supply AI to the Israeli military and for Trump’s domestic security campaign. Palantir’s billionaire founder Peter Thiel has questioned democracy, said that technology companies can "unilaterally change the world" and called technology "an incredible alternative to politics". Palantir’s contract began in 2024. The firm employed former Labour deputy leader and House of Lords member Tom Watson as a permanent senior lobbyist last month. Watson posted videos on X this week aimed at exposing "myths" about Palantir, including concerns that public services would become "locked in" to its systems, and refuted criticism from Green Party leader Zack Polanski.













